HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by O'Hagan, D. T. Articles by Illum, L. Search for Related Content PubMed PubMed Citation Articles by O'Hagan, D. T. Articles by Illum, L. Agricola Articles by O'Hagan, D. T. Articles by Illum, L.

Vaginal immunization of rats with a synthetic peptide from human immunodeficiency virus envelope glycoprotein

Daniel Rafferty^1,

¹ Department of Pharmaceutical Sciences, University of Nottingham, University Park, Nottingham NG7 2RD
and² Institute of Cancer Research, Chester Beatty Laboratories, Fulham Road, London SW3 6JB, U.K.

Local secretory immunity in the vagina may confer a degree of protection against heterosexual transmission of human immunodeficiency virus (HIV). Since the vagina has been shown to respond to local immunization, we have undertaken intravaginal immunization of rats with a 20-mer peptide (amino acid residues 102 to 121) of the HIV-1 envelope glycoprotein (gp120). The peptide was administered in combination with an ‘absorption enhancer’, lysophosphatidyl glycerol (LPG), which has previously been shown to promote the absorption of intravaginally administered peptides, while exerting only mild effects on epithelial membrane integrity. Intravaginal immunization with LPG and the peptide induced serum and vaginal wash IgA and IgG antibody responses which were enhanced in comparison to those after immunization with the peptide alone. Serum antibodies induced by both subcutaneous and intravaginal immunization were able to recognize recombinant HIV-1 gp120. However, the rat antiserum displayed no neutralizing activity against the virus. These results demonstrate that LPG is an effective immunological adjuvant for intravaginally administered peptide antigens. An alternative absorption enhancer, bestatin (BES), was not effective as an immunological adjuvant when administered intravaginally and blocked the adjuvant activity of LPG when BES and LPG were used in combination.

Present address: Department of Anatomy, Southern Illinois University, School of Medicine, Carbondale, Illinois 62901-6503, U.S.A.

Received 19 December 1991; accepted 8 April 1992.

This article has been cited by other articles:

				H. Echchannaoui, M. Bianchi, D. Baud, M. Bobst, J.-C. Stehle, and D. Nardelli-Haefliger Intravaginal Immunization of Mice with Recombinant Salmonella enterica Serovar Typhimurium Expressing Human Papillomavirus Type 16 Antigens as a Potential Route of Vaccination against Cervical Cancer Infect. Immun., May 1, 2008; 76(5): 1940 - 1951. [Abstract] [Full Text] [PDF]

				E. L. Parr and M. B. Parr Immunoglobulin G, Plasma Cells, and Lymphocytes in the Murine Vagina after Vaginal or Parenteral Immunization with Attenuated Herpes Simplex Virus Type 2 J. Virol., June 1, 1998; 72(6): 5137 - 5145. [Abstract] [Full Text] [PDF]

				T. C. VanCott, R. W. Kaminski, J. R. Mascola, V. S. Kalyanaraman, N. M. Wassef, C. R. Alving, J.T. Ulrich, G. H. Lowell, and D. L. Birx HIV-1 Neutralizing Antibodies in the Genital and Respiratory Tracts of Mice Intranasally Immunized with Oligomeric gp160 J. Immunol., February 15, 1998; 160(4): 2000 - 2012. [Abstract] [Full Text] [PDF]